Contents

Current Pharmaceutical Design, Volume 8 - Number 2

Preface

, 8(2): i

David W. Smith and Joseph P. Yevich


DOI: 10.2174/1381612023396564




A Review of Molecular Modeling Approaches to Pharmacophore Models and Structure-Activity Relationships of Ion Channel Modulators in CNS

, 8(2): 99 - 110

Y. Li and W. E. Harte


DOI: 10.2174/1381612023396546




Quantitative Structure-Activity Relationship Studies on Cholecystokinin Antagonists

, 8(2): 111 - 124

Satya P. Gupta


DOI: 10.2174/1381612023396500




Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing Drugs

, 8(2): 125 - 138

Fulvio Gualtieri, Dina Manetti, Maria Novella Romanelli and Carla Ghelardini


DOI: 10.2174/1381612023396582




The Potential Utility of 5-HT1A Receptor Antagonists in the Treatment of Cognitive Dysfunction Associated with Alzheimers Disease

, 8(2): 139 - 145

L. E. Schechter, L. A. Dawson and J. A. Harder


DOI: 10.2174/1381612023396483




Analysis of Overall Gene Expression Induced by Amphetamine and Phencyclidine: Novel Targets for the Treatment of Drug Psychosis and Schizophrenia

, 8(2): 147 - 153

Chihiro Ito


DOI: 10.2174/1381612023396528




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science